The Market Research Report on Binge Eating Disorder states the symptoms and treatment for the eating disorders (Central Nervous System). The Oncology for Binge Eating Disorder is described in the stage of development, drug target, route of administration and molecule type.

Offers from 10th May 2017 to 2nd June 2017
• All reports priced >=1,000 – 20% Discount – Single User; 25% Discount – Global Site License.
• Buy 2 Reports Get 1 Report Free
Binge eating disorder is a serious condition characterized by uncontrollable eating and resulting weight gain. The causes of binge-eating disorder are unknown. But family history, biological factors, long-term dieting and psychological issues increase your risk. Signs and symptoms include eating unusually large amounts of food, frequently eating alone, feeling that eating behavior is out of control and experiencing depression and anxiety. Treatment includes psychotherapy, medications and behavioral weight-loss programs.

To Get Discount on Report @ http://www.reportsnreports.com/contacts/discount.aspx?name=992890 .
The Pharmaceutical and Healthcare latest pipeline guide Binge Eating Disorder - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Binge Eating Disorder (Central Nervous System), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
Binge Eating Disorder (Central Nervous System) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
Purchase the Copy of Report @ http://www.reportsnreports.com/purchase.aspx?name=992890 .
Companies Involved in Therapeutics Development, covers:
• Chronos Therapeutics Ltd
• F. Hoffmann-La Roche Ltd
• Heptares Therapeutics Ltd
• Highland Therapeutics Inc
• Omeros Corp
• Opiant Pharmaceuticals Inc
• Shire Plc
• Sunovion Pharmaceuticals Inc
Scope of the Report
The pipeline guide provides a snapshot of the global therapeutic landscape of Binge Eating Disorder (Central Nervous System). The pipeline guide reviews pipeline therapeutics for Binge Eating Disorder (Central Nervous System) by companies and universities/research institutes based on information derived from company and industry-specific sources.
The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages. The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
The pipeline guide reviews key companies involved in Binge Eating Disorder (Central Nervous System) therapeutics and enlists all their major and minor projects. The pipeline guide evaluates Binge Eating Disorder (Central Nervous System) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
The pipeline guide encapsulates all the dormant and discontinued pipeline projects. The pipeline guide reviews latest news related to pipeline therapeutics for Binge Eating Disorder (Central Nervous System)
Inquire for the Report @ http://www.reportsnreports.com/contacts/inquirybeforebuy.aspx?name=992890 .
List of Tables
• Number of Products under Development for Binge Eating Disorder, H1 2017
• Number of Products under Development by Companies, H1 2017
• Products under Development by Companies, H1 2017
• Number of Products by Stage and Target, H1 2017
• Number of Products by Stage and Mechanism of Action, H1 2017
• Number of Products by Stage and Route of Administration, H1 2017
• Number of Products by Stage and Molecule Type, H1 2017
• Binge Eating Disorder - Pipeline by Chronos Therapeutics Ltd, H1 2017
• Binge Eating Disorder - Pipeline by Omeros Corp, H1 2017
• Binge Eating Disorder - Pipeline by Opiant Pharmaceuticals Inc, H1 2017
• Binge Eating Disorder - Pipeline by Shire Plc, H1 2017
• Binge Eating Disorder - Pipeline by Sunovion Pharmaceuticals Inc, H1 2017
Browse All Reports on Pharmaceuticals Market Research Reports.
Order report by calling ReportsnReports.com at +1 888 391 5441 OR send an email on [email protected] with Global Construction Industry in subject line and your contact details.
About Us:
ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets.